NCT07704801Active, not recruiting
CDK4/6 Inhibitors in Metastatic HR-Positive Breast Cancer
RETROSPECTIVE STUDY OF OUTCOME OF CDK4/6 INHIBITORS IN METASTATIC LUMINAL A AND LUMINAL B BREAST CANCER
Source: ClinicalTrials.gov · Last updated 15 Jul 2026
Brief summary (registry, in English)
This study is a retrospective review aimed at evaluating the real-world outcomes and clinical efficacy of CDK4/6 inhibitors (such as Palbociclib, Ribociclib, or Abemaciclib) in patients diagnosed with metastatic luminal A and luminal B breast cancer. The study will assess how patients responded to these treatments based on their specific breast cancer subtype (Luminal A vs. Luminal B) by reviewing their medical records.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 9 Jul 2026
- Start date
- 1 Jan 2021
- Primary completion date
- 1 Nov 2026
- Lead sponsor
- Sohag University
- Diseases
- Metastatic breast cancer
- NCT number
- NCT07704801
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Jan 2021 to the primary completion date, 1 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patients diagnosed with double malignancy
- patients with incomplete medical records
- patients with organ failure
Who the study is looking for
- patients who are more than 18 years old at time of diagnosis and less than 80 years
- metastatic breast cancer luminal A and luminal B of either sex
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sohag University Hospital Coordinator of this site? Confirm its status | Sohag | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.